What it is
Retatrutide (GLP-3) is a triple incretin agonist medication used in TWW's weight management protocols. In simple terms, it is meant to support weight management and metabolic improvement. Some peptides act like small biological messages, while others support peptide-adjacent pathways such as mitochondrial function, redox balance, or hormone signaling.
Retatrutide is a synthetic medication, not a naturally occurring peptide. It is designed to activate three natural metabolic hormone pathways: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon.
The practical goal is to understand what signal this peptide is trying to send, then decide whether that signal matches the person's goals, labs, symptoms, and overall health picture.
What it may help with
The larger idea is metabolic flexibility: helping the body shift away from storage mode and toward better appetite, glucose, fat-use, or energy-balance signaling when the rest of the program is in place. For Retatrutide (GLP-3), the suspected benefits come from the way this pathway appears to influence weight management and metabolic improvement. These are not guaranteed outcomes, but they explain why the peptide is considered in certain wellness protocols.
What it’s used for
In peptide protocols, this is usually considered as part of a broader plan rather than as a stand-alone “magic bullet.” At TWW, that means matching the peptide to the clinical pattern, the goal of care, and the other pieces of the plan such as nutrition, training, sleep, lab review, or recovery work.
- Medically supervised weight-management programs.
- Patients with obesity, visceral fat, insulin resistance, or metabolic risk where incretin therapy is appropriate.
- Body-composition plans that protect lean mass through protein, resistance training, and follow-up.